Rank | Gene Set | Z-score |
---|---|---|
1 | muscle filament sliding (GO:0030049) | 7.41832353 |
2 | actin-myosin filament sliding (GO:0033275) | 7.41832353 |
3 | sarcomere organization (GO:0045214) | 7.27608978 |
4 | response to muscle activity (GO:0014850) | 6.64984698 |
5 | cardiac myofibril assembly (GO:0055003) | 6.41917166 |
6 | regulation of skeletal muscle contraction (GO:0014819) | 6.38042762 |
7 | myofibril assembly (GO:0030239) | 6.33206935 |
8 | actin-mediated cell contraction (GO:0070252) | 6.09534201 |
9 | skeletal muscle fiber development (GO:0048741) | 5.91796760 |
10 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.77651719 |
11 | tricarboxylic acid cycle (GO:0006099) | 5.58667689 |
12 | carnitine shuttle (GO:0006853) | 5.48890816 |
13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.36542154 |
14 | myotube cell development (GO:0014904) | 5.34962368 |
15 | cardiac muscle contraction (GO:0060048) | 5.29322767 |
16 | plasma membrane repair (GO:0001778) | 5.22999991 |
17 | muscle system process (GO:0003012) | 5.14689094 |
18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.08897705 |
19 | fatty acid transmembrane transport (GO:1902001) | 5.06940910 |
20 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.96251753 |
21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.94801132 |
22 | striated muscle contraction (GO:0006941) | 4.84839724 |
23 | cardiac muscle cell development (GO:0055013) | 4.82978624 |
24 | 2-oxoglutarate metabolic process (GO:0006103) | 4.82478776 |
25 | lysine catabolic process (GO:0006554) | 4.76501702 |
26 | lysine metabolic process (GO:0006553) | 4.76501702 |
27 | muscle fiber development (GO:0048747) | 4.71600376 |
28 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.68400705 |
29 | actomyosin structure organization (GO:0031032) | 4.66732682 |
30 | actin filament-based movement (GO:0030048) | 4.52488402 |
31 | cardiac cell development (GO:0055006) | 4.51464041 |
32 | skeletal muscle tissue development (GO:0007519) | 4.48309420 |
33 | skeletal muscle contraction (GO:0003009) | 4.46952999 |
34 | glycogen biosynthetic process (GO:0005978) | 4.46022142 |
35 | glucan biosynthetic process (GO:0009250) | 4.46022142 |
36 | regulation of relaxation of muscle (GO:1901077) | 4.39086992 |
37 | heart process (GO:0003015) | 4.37943626 |
38 | heart contraction (GO:0060047) | 4.37943626 |
39 | muscle cell fate commitment (GO:0042693) | 4.35883572 |
40 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.33863518 |
41 | aspartate family amino acid catabolic process (GO:0009068) | 4.30932212 |
42 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.30803898 |
43 | regulation of actin filament-based movement (GO:1903115) | 4.29401295 |
44 | positive regulation of myotube differentiation (GO:0010831) | 4.27319574 |
45 | adult heart development (GO:0007512) | 4.26706851 |
46 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.25618289 |
47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.22624203 |
48 | cardiac muscle hypertrophy (GO:0003300) | 4.21853569 |
49 | carnitine transmembrane transport (GO:1902603) | 4.19943049 |
50 | muscle cell cellular homeostasis (GO:0046716) | 4.16874525 |
51 | fatty acid beta-oxidation (GO:0006635) | 4.13740421 |
52 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.13232618 |
53 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.09989820 |
54 | striated muscle hypertrophy (GO:0014897) | 4.06796936 |
55 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.06684739 |
56 | creatine metabolic process (GO:0006600) | 4.06185848 |
57 | striated muscle cell development (GO:0055002) | 4.03928172 |
58 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.03040036 |
59 | amino-acid betaine transport (GO:0015838) | 4.02740259 |
60 | carnitine transport (GO:0015879) | 4.02740259 |
61 | muscle tissue morphogenesis (GO:0060415) | 3.98765721 |
62 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.95532138 |
63 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.94119595 |
64 | skeletal muscle tissue regeneration (GO:0043403) | 3.93743503 |
65 | cardiac muscle adaptation (GO:0014887) | 3.93736479 |
66 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.93736479 |
67 | muscle hypertrophy in response to stress (GO:0003299) | 3.93736479 |
68 | striated muscle atrophy (GO:0014891) | 3.92232537 |
69 | regulation of cell communication by electrical coupling (GO:0010649) | 3.89254837 |
70 | NADH metabolic process (GO:0006734) | 3.88526645 |
71 | polysaccharide catabolic process (GO:0000272) | 3.85763102 |
72 | regulation of coenzyme metabolic process (GO:0051196) | 3.85070397 |
73 | regulation of cofactor metabolic process (GO:0051193) | 3.85070397 |
74 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.84474948 |
75 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.84474948 |
76 | heart trabecula formation (GO:0060347) | 3.83957131 |
77 | glyoxylate metabolic process (GO:0046487) | 3.81928063 |
78 | muscle organ development (GO:0007517) | 3.78597026 |
79 | muscle structure development (GO:0061061) | 3.77527262 |
80 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.74665928 |
81 | acetyl-CoA metabolic process (GO:0006084) | 3.74665147 |
82 | regulation of sarcomere organization (GO:0060297) | 3.73971698 |
83 | muscle adaptation (GO:0043500) | 3.73582205 |
84 | regulation of striated muscle contraction (GO:0006942) | 3.72531818 |
85 | cellular ketone body metabolic process (GO:0046950) | 3.71520299 |
86 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.69254748 |
87 | oxidative phosphorylation (GO:0006119) | 3.68819609 |
88 | glycogen catabolic process (GO:0005980) | 3.68058137 |
89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.66047716 |
90 | muscle hypertrophy (GO:0014896) | 3.63476964 |
91 | oxaloacetate metabolic process (GO:0006107) | 3.62222810 |
92 | fatty acid catabolic process (GO:0009062) | 3.60705404 |
93 | fatty acid oxidation (GO:0019395) | 3.59262468 |
94 | respiratory electron transport chain (GO:0022904) | 3.58826283 |
95 | glycogen metabolic process (GO:0005977) | 3.57622344 |
96 | kynurenine metabolic process (GO:0070189) | 3.57547744 |
97 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.54349723 |
98 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.52945114 |
99 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.52945114 |
100 | succinate metabolic process (GO:0006105) | 3.52941086 |
101 | skeletal muscle adaptation (GO:0043501) | 3.52081188 |
102 | short-chain fatty acid metabolic process (GO:0046459) | 3.51830028 |
103 | lipid oxidation (GO:0034440) | 3.51771002 |
104 | gluconeogenesis (GO:0006094) | 3.50957297 |
105 | regulation of ATPase activity (GO:0043462) | 3.50820653 |
106 | regulation of ATP catabolic process (GO:1903289) | 3.50820653 |
107 | glucan metabolic process (GO:0044042) | 3.50730830 |
108 | cellular glucan metabolic process (GO:0006073) | 3.50730830 |
109 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.48311764 |
110 | ATP synthesis coupled proton transport (GO:0015986) | 3.48311764 |
111 | muscle atrophy (GO:0014889) | 3.48269046 |
112 | electron transport chain (GO:0022900) | 3.47854002 |
113 | regulation of fatty acid oxidation (GO:0046320) | 3.47500925 |
114 | muscle cell development (GO:0055001) | 3.47367551 |
115 | regulation of myoblast differentiation (GO:0045661) | 3.47343903 |
116 | L-phenylalanine metabolic process (GO:0006558) | 3.47211386 |
117 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.47211386 |
118 | glucan catabolic process (GO:0009251) | 3.46897938 |
119 | branched-chain amino acid catabolic process (GO:0009083) | 3.46817557 |
120 | L-phenylalanine catabolic process (GO:0006559) | 3.41211853 |
121 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.41211853 |
122 | response to activity (GO:0014823) | 3.40906938 |
123 | regulation of muscle system process (GO:0090257) | 3.39923319 |
124 | positive regulation of myoblast differentiation (GO:0045663) | 3.39094704 |
125 | regulation of muscle contraction (GO:0006937) | 3.38404267 |
126 | tricarboxylic acid metabolic process (GO:0072350) | 3.37318546 |
127 | muscle contraction (GO:0006936) | 3.36603073 |
128 | response to inactivity (GO:0014854) | 3.32399449 |
129 | fructose metabolic process (GO:0006000) | 3.31362441 |
130 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.31319995 |
131 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31033998 |
132 | regulation of membrane repolarization (GO:0060306) | 3.29111343 |
133 | positive regulation of cation channel activity (GO:2001259) | 3.28617271 |
134 | striated muscle tissue development (GO:0014706) | 3.27685859 |
135 | monocarboxylic acid catabolic process (GO:0072329) | 3.27256330 |
136 | muscle organ morphogenesis (GO:0048644) | 3.26099326 |
137 | regulation of the force of heart contraction (GO:0002026) | 3.26021308 |
138 | regulation of sulfur metabolic process (GO:0042762) | 3.25353651 |
139 | amino-acid betaine metabolic process (GO:0006577) | 3.25187091 |
140 | cellular polysaccharide catabolic process (GO:0044247) | 3.24721279 |
141 | relaxation of muscle (GO:0090075) | 3.23682474 |
142 | carnitine metabolic process (GO:0009437) | 3.23339933 |
143 | quaternary ammonium group transport (GO:0015697) | 3.23010411 |
144 | branched-chain amino acid metabolic process (GO:0009081) | 3.22513536 |
145 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.21511433 |
146 | striated muscle adaptation (GO:0014888) | 3.19184069 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.69746201 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.40500843 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16515927 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.83229714 |
5 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.57414369 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.23975002 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.07717641 |
8 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.87521082 |
9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.63328156 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.58700737 |
11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.42464909 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.07382634 |
13 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.92181238 |
14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.90360341 |
15 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.90360341 |
16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.80626940 |
17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.48384086 |
18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.47403731 |
19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45581566 |
20 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.22665330 |
21 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.97231898 |
22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96508343 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96382968 |
24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.91615600 |
25 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90532791 |
26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89054575 |
27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.68120213 |
28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.63866656 |
29 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.63463627 |
30 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.48275474 |
31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47819229 |
32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41572398 |
33 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.41509727 |
34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39561469 |
35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39397798 |
36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33602095 |
37 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.31091582 |
38 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31040306 |
39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28165258 |
40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27990846 |
41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.25103212 |
42 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.23969584 |
43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22355245 |
44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19396404 |
45 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.19248195 |
46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19006117 |
47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17026787 |
48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15272999 |
49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14914148 |
50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13530477 |
51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12709518 |
52 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12678095 |
53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10976840 |
54 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08378891 |
55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08342554 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07980968 |
57 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05060154 |
58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04975411 |
59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95693324 |
60 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.95095700 |
61 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.92992329 |
62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92082701 |
63 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.91320013 |
64 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91299014 |
65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89485137 |
66 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88599108 |
67 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88380798 |
68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87366846 |
69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.86791155 |
70 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86354549 |
71 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.86163946 |
72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86078015 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85746712 |
74 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84878632 |
75 | P68_20966046_ChIP-Seq_HELA_Human | 0.84649359 |
76 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.84129125 |
77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83454922 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83453124 |
79 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83252954 |
80 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.82812208 |
81 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.82728717 |
82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82284530 |
83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82128953 |
84 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.80842313 |
85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80800931 |
86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80730159 |
87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80722741 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80718053 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79783623 |
90 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.79480661 |
91 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78214907 |
92 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.76997300 |
93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76164265 |
94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76079027 |
95 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76057783 |
96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75339143 |
97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74047448 |
98 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.73953230 |
99 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.73614262 |
100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.73312944 |
101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.72879865 |
102 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.72366808 |
103 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.71956296 |
104 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.71523884 |
105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.71326642 |
106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71318278 |
107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70325016 |
108 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.69902660 |
109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.69362564 |
110 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69309908 |
111 | SA1_27219007_Chip-Seq_Bcells_Human | 0.68920261 |
112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.68781974 |
113 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.68670198 |
114 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.68589923 |
115 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.68492128 |
116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68466438 |
117 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.68381937 |
118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.68334320 |
119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67904594 |
120 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.67557820 |
121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67114123 |
122 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.66594047 |
123 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.66252263 |
124 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.65793049 |
125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65455709 |
126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65195639 |
127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65186999 |
128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.64978075 |
129 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.64841940 |
130 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.64607822 |
131 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.63792684 |
132 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.63498230 |
133 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62995455 |
134 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.62886323 |
135 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.62218612 |
136 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.62030835 |
137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61756585 |
138 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61298660 |
139 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.60698190 |
140 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.60467148 |
141 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.60420448 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 5.79187379 |
2 | MP0003646_muscle_fatigue | 5.54658323 |
3 | MP0000751_myopathy | 4.74339643 |
4 | MP0000749_muscle_degeneration | 4.36013605 |
5 | MP0004084_abnormal_cardiac_muscle | 4.32602876 |
6 | MP0004036_abnormal_muscle_relaxation | 4.02219857 |
7 | MP0004215_abnormal_myocardial_fiber | 3.45056087 |
8 | MP0004145_abnormal_muscle_electrophysio | 3.33762249 |
9 | MP0005330_cardiomyopathy | 3.31751641 |
10 | MP0004087_abnormal_muscle_fiber | 2.95194256 |
11 | MP0002139_abnormal_hepatobiliary_system | 2.93009883 |
12 | MP0002106_abnormal_muscle_physiology | 2.64663834 |
13 | MP0005620_abnormal_muscle_contractility | 2.62632822 |
14 | MP0005360_urolithiasis | 2.62469476 |
15 | MP0004130_abnormal_muscle_cell | 2.62002945 |
16 | MP0002269_muscular_atrophy | 2.61628265 |
17 | MP0003806_abnormal_nucleotide_metabolis | 2.58036743 |
18 | MP0002972_abnormal_cardiac_muscle | 2.53647887 |
19 | MP0005085_abnormal_gallbladder_physiolo | 2.51967411 |
20 | MP0000750_abnormal_muscle_regeneration | 2.50961800 |
21 | MP0000747_muscle_weakness | 2.45235773 |
22 | MP0006036_abnormal_mitochondrial_physio | 2.21124088 |
23 | MP0000759_abnormal_skeletal_muscle | 2.19057841 |
24 | MP0005365_abnormal_bile_salt | 2.17902689 |
25 | MP0003137_abnormal_impulse_conducting | 2.16569168 |
26 | MP0005369_muscle_phenotype | 2.14709910 |
27 | MP0008775_abnormal_heart_ventricle | 2.12499338 |
28 | MP0010630_abnormal_cardiac_muscle | 2.11189847 |
29 | MP0005385_cardiovascular_system_phenoty | 2.07913394 |
30 | MP0001544_abnormal_cardiovascular_syste | 2.07913394 |
31 | MP0006138_congestive_heart_failure | 1.85338652 |
32 | MP0004484_altered_response_of | 1.83335804 |
33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.81301749 |
34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74703569 |
35 | MP0004233_abnormal_muscle_weight | 1.69277911 |
36 | MP0002332_abnormal_exercise_endurance | 1.61533841 |
37 | MP0005666_abnormal_adipose_tissue | 1.50857242 |
38 | MP0003252_abnormal_bile_duct | 1.50341266 |
39 | MP0004085_abnormal_heartbeat | 1.49262360 |
40 | MP0005083_abnormal_biliary_tract | 1.44198853 |
41 | MP0003828_pulmonary_edema | 1.41842663 |
42 | MP0009840_abnormal_foam_cell | 1.39351628 |
43 | MP0005332_abnormal_amino_acid | 1.35466606 |
44 | MP0005670_abnormal_white_adipose | 1.35178114 |
45 | MP0003195_calcinosis | 1.34242990 |
46 | MP0005451_abnormal_body_composition | 1.33887298 |
47 | MP0002127_abnormal_cardiovascular_syste | 1.28530244 |
48 | MP0006035_abnormal_mitochondrial_morpho | 1.25944135 |
49 | MP0010329_abnormal_lipoprotein_level | 1.24715984 |
50 | MP0003950_abnormal_plasma_membrane | 1.24222829 |
51 | MP0004270_analgesia | 1.24152021 |
52 | MP0005319_abnormal_enzyme/_coenzyme | 1.19711294 |
53 | MP0004510_myositis | 1.18531771 |
54 | MP0005266_abnormal_metabolism | 1.14313166 |
55 | MP0004185_abnormal_adipocyte_glucose | 1.07811309 |
56 | MP0002118_abnormal_lipid_homeostasis | 1.02674459 |
57 | MP0003705_abnormal_hypodermis_morpholog | 1.00868467 |
58 | MP0001661_extended_life_span | 0.96126962 |
59 | MP0002108_abnormal_muscle_morphology | 0.96010898 |
60 | MP0002971_abnormal_brown_adipose | 0.95042881 |
61 | MP0000343_altered_response_to | 0.92475422 |
62 | MP0005375_adipose_tissue_phenotype | 0.91742741 |
63 | MP0010368_abnormal_lymphatic_system | 0.91710895 |
64 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91384516 |
65 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88600609 |
66 | MP0004043_abnormal_pH_regulation | 0.88174426 |
67 | MP0000266_abnormal_heart_morphology | 0.87378578 |
68 | MP0002234_abnormal_pharynx_morphology | 0.85161768 |
69 | MP0000230_abnormal_systemic_arterial | 0.82947517 |
70 | MP0000609_abnormal_liver_physiology | 0.80590739 |
71 | MP0001666_abnormal_nutrient_absorption | 0.78317871 |
72 | MP0005165_increased_susceptibility_to | 0.77614200 |
73 | MP0002078_abnormal_glucose_homeostasis | 0.74329869 |
74 | MP0000733_abnormal_muscle_development | 0.71854247 |
75 | MP0003191_abnormal_cellular_cholesterol | 0.71649239 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.68318926 |
77 | MP0003045_fibrosis | 0.67402552 |
78 | MP0009780_abnormal_chondrocyte_physiolo | 0.66857165 |
79 | MP0002128_abnormal_blood_circulation | 0.62088933 |
80 | MP0003279_aneurysm | 0.61256659 |
81 | MP0004147_increased_porphyrin_level | 0.60040330 |
82 | MP0009643_abnormal_urine_homeostasis | 0.59903932 |
83 | MP0005334_abnormal_fat_pad | 0.56786241 |
84 | MP0001299_abnormal_eye_distance/ | 0.55061594 |
85 | MP0005535_abnormal_body_temperature | 0.54299708 |
86 | MP0000372_irregular_coat_pigmentation | 0.52362665 |
87 | MP0005376_homeostasis/metabolism_phenot | 0.52057968 |
88 | MP0002138_abnormal_hepatobiliary_system | 0.48441719 |
89 | MP0003186_abnormal_redox_activity | 0.48211723 |
90 | MP0001764_abnormal_homeostasis | 0.46224888 |
91 | MP0003879_abnormal_hair_cell | 0.44704779 |
92 | MP0008961_abnormal_basal_metabolism | 0.43025532 |
93 | MP0009697_abnormal_copulation | 0.40960248 |
94 | MP0005187_abnormal_penis_morphology | 0.38818759 |
95 | MP0002909_abnormal_adrenal_gland | 0.38612364 |
96 | MP0000598_abnormal_liver_morphology | 0.38411829 |
97 | MP0005167_abnormal_blood-brain_barrier | 0.38346005 |
98 | MP0004134_abnormal_chest_morphology | 0.38342169 |
99 | MP0008569_lethality_at_weaning | 0.37190385 |
100 | MP0009642_abnormal_blood_homeostasis | 0.37024118 |
101 | MP0004019_abnormal_vitamin_homeostasis | 0.35946459 |
102 | MP0002822_catalepsy | 0.35436068 |
103 | MP0002638_abnormal_pupillary_reflex | 0.34937328 |
104 | MP0003566_abnormal_cell_adhesion | 0.34844744 |
105 | MP0000767_abnormal_smooth_muscle | 0.34734987 |
106 | MP0000013_abnormal_adipose_tissue | 0.34498167 |
107 | MP0010030_abnormal_orbit_morphology | 0.34403748 |
108 | MP0000003_abnormal_adipose_tissue | 0.34156556 |
109 | MP0005636_abnormal_mineral_homeostasis | 0.33466247 |
110 | MP0000762_abnormal_tongue_morphology | 0.33321667 |
111 | MP0009115_abnormal_fat_cell | 0.32621633 |
112 | MP0001879_abnormal_lymphatic_vessel | 0.31821318 |
113 | MP0005166_decreased_susceptibility_to | 0.31386197 |
114 | MP0003948_abnormal_gas_homeostasis | 0.30868645 |
115 | MP0001346_abnormal_lacrimal_gland | 0.29239690 |
116 | MP0005452_abnormal_adipose_tissue | 0.28166194 |
117 | MP0001853_heart_inflammation | 0.27664230 |
118 | MP0002114_abnormal_axial_skeleton | 0.26349245 |
119 | MP0004142_abnormal_muscle_tone | 0.25790904 |
120 | MP0002896_abnormal_bone_mineralization | 0.25300863 |
121 | MP0009672_abnormal_birth_weight | 0.23500312 |
122 | MP0002249_abnormal_larynx_morphology | 0.19974264 |
123 | MP0009250_abnormal_appendicular_skeleto | 0.19697027 |
124 | MP0001943_abnormal_respiration | 0.18825546 |
125 | MP0004858_abnormal_nervous_system | 0.17643988 |
126 | MP0002734_abnormal_mechanical_nocicepti | 0.16596290 |
127 | MP0002066_abnormal_motor_capabilities/c | 0.15133508 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Exercise-induced myalgia (HP:0003738) | 6.82421461 |
2 | Exercise-induced muscle cramps (HP:0003710) | 6.62912539 |
3 | Calf muscle hypertrophy (HP:0008981) | 6.28458020 |
4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.16185693 |
5 | Sudden death (HP:0001699) | 5.94688893 |
6 | Myoglobinuria (HP:0002913) | 5.31507266 |
7 | Ventricular tachycardia (HP:0004756) | 5.13108964 |
8 | Muscle fiber splitting (HP:0003555) | 5.07499180 |
9 | Hyporeflexia of lower limbs (HP:0002600) | 4.77695764 |
10 | Abnormality of the calf musculature (HP:0001430) | 4.66492155 |
11 | Muscle fiber inclusion bodies (HP:0100299) | 4.65573007 |
12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.61808317 |
13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.46192229 |
14 | Subaortic stenosis (HP:0001682) | 4.44837031 |
15 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.44837031 |
16 | Rhabdomyolysis (HP:0003201) | 4.30693001 |
17 | EMG: myopathic abnormalities (HP:0003458) | 4.18107373 |
18 | Atrial fibrillation (HP:0005110) | 4.04072969 |
19 | Lipoatrophy (HP:0100578) | 4.02400894 |
20 | Calcaneovalgus deformity (HP:0001848) | 3.96304219 |
21 | Nemaline bodies (HP:0003798) | 3.89179147 |
22 | Type 1 muscle fiber predominance (HP:0003803) | 3.88334639 |
23 | Increased connective tissue (HP:0009025) | 3.83754195 |
24 | Difficulty running (HP:0009046) | 3.81540692 |
25 | Asymmetric septal hypertrophy (HP:0001670) | 3.75934001 |
26 | Primary atrial arrhythmia (HP:0001692) | 3.74231559 |
27 | Supraventricular tachycardia (HP:0004755) | 3.61539508 |
28 | Right ventricular cardiomyopathy (HP:0011663) | 3.60235237 |
29 | Absent phalangeal crease (HP:0006109) | 3.56082313 |
30 | Supraventricular arrhythmia (HP:0005115) | 3.53413083 |
31 | Deformed tarsal bones (HP:0008119) | 3.50246130 |
32 | Palpitations (HP:0001962) | 3.49156689 |
33 | Dilated cardiomyopathy (HP:0001644) | 3.48993017 |
34 | Myotonia (HP:0002486) | 3.37297324 |
35 | Muscle stiffness (HP:0003552) | 3.31397179 |
36 | Malignant hyperthermia (HP:0002047) | 3.29290146 |
37 | Ketoacidosis (HP:0001993) | 3.25341976 |
38 | Bundle branch block (HP:0011710) | 3.23311723 |
39 | Frequent falls (HP:0002359) | 3.20336069 |
40 | Ketosis (HP:0001946) | 3.18966880 |
41 | Hypoglycemic coma (HP:0001325) | 3.15304494 |
42 | Syncope (HP:0001279) | 3.12506502 |
43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.00698842 |
44 | Ventricular arrhythmia (HP:0004308) | 2.96064665 |
45 | Abnormal finger flexion creases (HP:0006143) | 2.93480825 |
46 | Hepatic necrosis (HP:0002605) | 2.93195915 |
47 | Prolonged QT interval (HP:0001657) | 2.91558231 |
48 | Heart block (HP:0012722) | 2.87388020 |
49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.85589280 |
50 | Cerebral edema (HP:0002181) | 2.78300593 |
51 | Distal arthrogryposis (HP:0005684) | 2.76946804 |
52 | Hyperammonemia (HP:0001987) | 2.76580696 |
53 | Dicarboxylic aciduria (HP:0003215) | 2.75643497 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75643497 |
55 | Difficulty climbing stairs (HP:0003551) | 2.74456027 |
56 | Atrioventricular block (HP:0001678) | 2.74003052 |
57 | Fetal akinesia sequence (HP:0001989) | 2.72485150 |
58 | Abnormal atrioventricular conduction (HP:0005150) | 2.69382135 |
59 | Bulbar palsy (HP:0001283) | 2.68512651 |
60 | Distal lower limb muscle weakness (HP:0009053) | 2.66052130 |
61 | Weak cry (HP:0001612) | 2.65604983 |
62 | Distal lower limb amyotrophy (HP:0008944) | 2.65420063 |
63 | Myopathic facies (HP:0002058) | 2.65337452 |
64 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.64482663 |
65 | Areflexia of lower limbs (HP:0002522) | 2.63429204 |
66 | Acute encephalopathy (HP:0006846) | 2.62716931 |
67 | Acute necrotizing encephalopathy (HP:0006965) | 2.60097371 |
68 | Gowers sign (HP:0003391) | 2.59092159 |
69 | Hyperglycinuria (HP:0003108) | 2.57557003 |
70 | Neck muscle weakness (HP:0000467) | 2.53495006 |
71 | Abnormality of the neuromuscular junction (HP:0003398) | 2.49071596 |
72 | Fatigable weakness (HP:0003473) | 2.49071596 |
73 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.47417888 |
74 | Round ear (HP:0100830) | 2.47355926 |
75 | Increased variability in muscle fiber diameter (HP:0003557) | 2.46131046 |
76 | Hepatocellular necrosis (HP:0001404) | 2.45402023 |
77 | Increased muscle lipid content (HP:0009058) | 2.42916207 |
78 | Scapular winging (HP:0003691) | 2.41767039 |
79 | Rimmed vacuoles (HP:0003805) | 2.38870322 |
80 | Ventricular fibrillation (HP:0001663) | 2.37646093 |
81 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.37345191 |
82 | Abnormality of glycine metabolism (HP:0010895) | 2.37345191 |
83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.36232874 |
84 | Cholelithiasis (HP:0001081) | 2.32499643 |
85 | Ragged-red muscle fibers (HP:0003200) | 2.31801136 |
86 | Progressive muscle weakness (HP:0003323) | 2.31505702 |
87 | Abnormality of the calcaneus (HP:0008364) | 2.29200581 |
88 | Hypoalphalipoproteinemia (HP:0003233) | 2.28770477 |
89 | Hip contracture (HP:0003273) | 2.26171140 |
90 | Abnormality of the foot musculature (HP:0001436) | 2.24609199 |
91 | Xanthomatosis (HP:0000991) | 2.21898987 |
92 | Slender build (HP:0001533) | 2.21534164 |
93 | Popliteal pterygium (HP:0009756) | 2.20508739 |
94 | Mitochondrial inheritance (HP:0001427) | 2.19043460 |
95 | Intrahepatic cholestasis (HP:0001406) | 2.18414786 |
96 | Metabolic acidosis (HP:0001942) | 2.17019978 |
97 | Left ventricular hypertrophy (HP:0001712) | 2.16488047 |
98 | EMG: neuropathic changes (HP:0003445) | 2.16006609 |
99 | Increased CSF lactate (HP:0002490) | 2.13874256 |
100 | Abnormal gallbladder morphology (HP:0012437) | 2.13570331 |
101 | Hyperglycinemia (HP:0002154) | 2.13474942 |
102 | Progressive macrocephaly (HP:0004481) | 2.13263093 |
103 | Limb-girdle muscle atrophy (HP:0003797) | 2.12363642 |
104 | Lactic acidosis (HP:0003128) | 2.11543079 |
105 | Generalized aminoaciduria (HP:0002909) | 2.11432814 |
106 | Deep venous thrombosis (HP:0002625) | 2.10816800 |
107 | Exercise intolerance (HP:0003546) | 2.09164366 |
108 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08393489 |
109 | Gout (HP:0001997) | 2.07966394 |
110 | Abnormal EKG (HP:0003115) | 2.07250924 |
111 | Increased intramyocellular lipid droplets (HP:0012240) | 2.06770140 |
112 | Spinal rigidity (HP:0003306) | 2.06017813 |
113 | Conjunctival hamartoma (HP:0100780) | 2.05788714 |
114 | Proximal amyotrophy (HP:0007126) | 2.05499977 |
115 | Ulnar deviation of the wrist (HP:0003049) | 2.04953399 |
116 | Hyperkalemia (HP:0002153) | 2.04639130 |
117 | Generalized muscle weakness (HP:0003324) | 2.04601355 |
118 | Foot dorsiflexor weakness (HP:0009027) | 2.02140153 |
119 | Palmoplantar keratoderma (HP:0000982) | 2.02115821 |
120 | Waddling gait (HP:0002515) | 2.02032796 |
121 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99083583 |
122 | Lethargy (HP:0001254) | 1.98840023 |
123 | Hyperlipoproteinemia (HP:0010980) | 1.98243004 |
124 | Hypolipoproteinemia (HP:0010981) | 1.97754063 |
125 | Lower limb amyotrophy (HP:0007210) | 1.97617980 |
126 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.94552307 |
127 | Testicular atrophy (HP:0000029) | 1.92146125 |
128 | Type 2 muscle fiber atrophy (HP:0003554) | 1.89762487 |
129 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.89410499 |
130 | Muscular dystrophy (HP:0003560) | 1.86332112 |
131 | Abnormality of glycolysis (HP:0004366) | 1.85265910 |
132 | Muscle fiber atrophy (HP:0100295) | 1.76360413 |
133 | Limb-girdle muscle weakness (HP:0003325) | 1.67218449 |
134 | Metatarsus adductus (HP:0001840) | 1.63958557 |
135 | Long clavicles (HP:0000890) | 1.61773353 |
136 | Facial diplegia (HP:0001349) | 1.61070965 |
137 | Abnormality of placental membranes (HP:0011409) | 1.59549537 |
138 | Amniotic constriction ring (HP:0009775) | 1.59549537 |
139 | Nonprogressive disorder (HP:0003680) | 1.58581654 |
140 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.57449947 |
141 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.57449947 |
142 | Limited hip movement (HP:0008800) | 1.51527339 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 6.35962979 |
2 | TTN | 6.04875281 |
3 | PHKG1 | 4.25101840 |
4 | PHKG2 | 4.25101840 |
5 | BCKDK | 3.98905552 |
6 | PDK3 | 2.95878443 |
7 | PDK4 | 2.95878443 |
8 | MYLK | 2.93556964 |
9 | PKN2 | 2.64172727 |
10 | TRIB3 | 2.55333453 |
11 | PINK1 | 2.32621208 |
12 | NEK1 | 2.31304572 |
13 | PIK3CA | 2.29705304 |
14 | LMTK2 | 2.22078077 |
15 | DMPK | 2.21364035 |
16 | MUSK | 2.00528994 |
17 | MAP2K3 | 1.79376523 |
18 | PDK2 | 1.76557152 |
19 | STK24 | 1.69110139 |
20 | PIK3CG | 1.58620010 |
21 | TIE1 | 1.56843987 |
22 | MAP3K7 | 1.50648623 |
23 | NME1 | 1.36177291 |
24 | MAPK12 | 1.33559026 |
25 | MOS | 1.29787401 |
26 | STK38L | 1.17664190 |
27 | SIK1 | 1.09827965 |
28 | EEF2K | 1.07851196 |
29 | LIMK1 | 1.05419220 |
30 | MAP2K4 | 1.00995524 |
31 | MAP3K3 | 0.99202040 |
32 | PAK3 | 0.98275956 |
33 | PRKAA2 | 0.98027864 |
34 | INSRR | 0.98000752 |
35 | MARK1 | 0.97585520 |
36 | FLT3 | 0.96247961 |
37 | PRKAA1 | 0.95087990 |
38 | ZAK | 0.92434618 |
39 | PRKD1 | 0.91443319 |
40 | WNK4 | 0.90489942 |
41 | ILK | 0.84760217 |
42 | CCNB1 | 0.84722081 |
43 | MAP3K5 | 0.83479095 |
44 | CAMK2D | 0.82403574 |
45 | DYRK1B | 0.81075193 |
46 | FGFR4 | 0.80923307 |
47 | MAPKAPK3 | 0.76463708 |
48 | RIPK1 | 0.75636939 |
49 | GRK7 | 0.72771444 |
50 | NEK9 | 0.71772226 |
51 | PKN1 | 0.70695782 |
52 | ROCK1 | 0.69558916 |
53 | ERN1 | 0.66528596 |
54 | MAP2K6 | 0.66487720 |
55 | TRPM7 | 0.62372808 |
56 | MAPK11 | 0.61617424 |
57 | MAP2K1 | 0.60941449 |
58 | STK4 | 0.60440914 |
59 | CDC42BPA | 0.58934605 |
60 | EPHB1 | 0.58261837 |
61 | KDR | 0.57852717 |
62 | ERBB3 | 0.55658395 |
63 | CAMK2G | 0.53858266 |
64 | KSR2 | 0.53281280 |
65 | MAP3K11 | 0.51646629 |
66 | MAP3K13 | 0.50878215 |
67 | DAPK3 | 0.50802822 |
68 | CAMK4 | 0.50108486 |
69 | PTK6 | 0.50011090 |
70 | TGFBR2 | 0.46957997 |
71 | PRKACB | 0.46483169 |
72 | STK38 | 0.46006542 |
73 | AKT2 | 0.45314410 |
74 | PDGFRA | 0.40836304 |
75 | CAMK2B | 0.39991672 |
76 | PRKACG | 0.39069861 |
77 | ICK | 0.38586403 |
78 | PDPK1 | 0.38131217 |
79 | PRPF4B | 0.36031734 |
80 | RPS6KC1 | 0.35379911 |
81 | RPS6KL1 | 0.35379911 |
82 | PRKACA | 0.35294858 |
83 | CAMK2A | 0.34279543 |
84 | LATS1 | 0.33379175 |
85 | MAP3K10 | 0.33359068 |
86 | PTK2B | 0.32573460 |
87 | MARK2 | 0.31784571 |
88 | TBK1 | 0.30994517 |
89 | RPS6KA6 | 0.29231811 |
90 | SGK2 | 0.29000824 |
91 | MAP3K6 | 0.28362678 |
92 | PDK1 | 0.27706383 |
93 | TAOK2 | 0.27265225 |
94 | ROCK2 | 0.25366717 |
95 | NME2 | 0.25353766 |
96 | SGK3 | 0.25272803 |
97 | MAPK10 | 0.24882107 |
98 | WNK1 | 0.24284525 |
99 | MAPK4 | 0.23127686 |
100 | CAMK1 | 0.22308081 |
101 | TAOK1 | 0.21822884 |
102 | ABL2 | 0.21732636 |
103 | JAK2 | 0.21688863 |
104 | RPS6KA1 | 0.20580263 |
105 | PRKG1 | 0.20486683 |
106 | STK39 | 0.19845143 |
107 | MAPK7 | 0.19720039 |
108 | ARAF | 0.19571198 |
109 | RPS6KB1 | 0.19219421 |
110 | RPS6KB2 | 0.19216059 |
111 | JAK1 | 0.18972510 |
112 | ZAP70 | 0.18653875 |
113 | EPHA3 | 0.18489908 |
114 | MTOR | 0.18314807 |
115 | PRKCH | 0.17625990 |
116 | MAP3K1 | 0.16896864 |
117 | RPS6KA3 | 0.16776116 |
118 | SGK1 | 0.16310695 |
119 | TYK2 | 0.16135811 |
120 | MARK3 | 0.15348928 |
121 | SGK223 | 0.12280687 |
122 | SGK494 | 0.12280687 |
123 | EPHB2 | 0.11915778 |
124 | RAF1 | 0.10699626 |
125 | LATS2 | 0.10610264 |
126 | MAPK13 | 0.09578207 |
127 | PRKCE | 0.09533033 |
128 | STK11 | 0.09416888 |
129 | NLK | 0.08160717 |
130 | KSR1 | 0.07890551 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.26355959 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.91373925 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.81048719 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.35067978 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.22546111 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.89898548 |
7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.83255494 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59170788 |
9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.44723760 |
10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37743996 |
11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.24307089 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23957811 |
13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.15914796 |
14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.14724945 |
15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.13899852 |
16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.13711959 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13265780 |
18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.11909108 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.04100464 |
20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74798588 |
21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.73267880 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70047812 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66596589 |
24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.63533602 |
25 | Peroxisome_Homo sapiens_hsa04146 | 1.63213940 |
26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62798176 |
27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62057929 |
28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.57238339 |
29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55718512 |
30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54658701 |
31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50956712 |
32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42432095 |
33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42378685 |
34 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.40368525 |
35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39461942 |
36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22416832 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.22361165 |
38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20112397 |
39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14361797 |
40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.12776569 |
41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97637859 |
42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94661306 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92168232 |
44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91746990 |
45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91480813 |
46 | Renin secretion_Homo sapiens_hsa04924 | 0.90772330 |
47 | Insulin resistance_Homo sapiens_hsa04931 | 0.90588980 |
48 | Lysine degradation_Homo sapiens_hsa00310 | 0.90551205 |
49 | Bile secretion_Homo sapiens_hsa04976 | 0.86848368 |
50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83684462 |
51 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.82743327 |
52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81921964 |
53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80250051 |
54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80118374 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78871195 |
56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78459877 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76637374 |
58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75494066 |
59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74638814 |
60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74299584 |
61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73477193 |
62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72208971 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70327920 |
64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68098086 |
65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67189254 |
66 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65704885 |
67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64863728 |
68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.60834702 |
69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59617623 |
70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59305374 |
71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57816387 |
72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55722250 |
73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55634868 |
74 | ABC transporters_Homo sapiens_hsa02010 | 0.54533681 |
75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53034460 |
76 | Insulin secretion_Homo sapiens_hsa04911 | 0.52212968 |
77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50119581 |
78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49954648 |
79 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48820809 |
80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48248738 |
81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47855110 |
82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46987502 |
83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45013025 |
84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42497242 |
85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41838870 |
86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41827988 |
87 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41335247 |
88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39228115 |
89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37366536 |
90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35339963 |
91 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35109419 |
92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34436133 |
93 | Salivary secretion_Homo sapiens_hsa04970 | 0.34054891 |
94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32311761 |
95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31703137 |
96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29776340 |
97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28575201 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28557802 |
99 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27005470 |
100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.25730556 |
101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24128557 |
102 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.23656673 |
103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23517132 |
104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23213212 |
105 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.21942360 |
106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21809970 |
107 | Platelet activation_Homo sapiens_hsa04611 | 0.21716336 |
108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21478931 |
109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20782609 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19102909 |
111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18183364 |
112 | Adherens junction_Homo sapiens_hsa04520 | 0.16804915 |
113 | Melanogenesis_Homo sapiens_hsa04916 | 0.16636881 |
114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.16514844 |
115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15825673 |
116 | Tight junction_Homo sapiens_hsa04530 | 0.14890135 |
117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.14625834 |
118 | Long-term depression_Homo sapiens_hsa04730 | 0.13912853 |
119 | Focal adhesion_Homo sapiens_hsa04510 | 0.13823150 |
120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12282618 |
121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12216694 |
122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.10597977 |
123 | Glioma_Homo sapiens_hsa05214 | 0.10203110 |
124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.09654797 |
125 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07166987 |
126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06835739 |
127 | Gap junction_Homo sapiens_hsa04540 | 0.05695118 |
128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.03339504 |
129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.00277389 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0264355 |
131 | Amoebiasis_Homo sapiens_hsa05146 | -0.0203115 |
132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0082461 |
133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | -0.0072623 |